Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues.

Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A, Ezewudo M, Farhat MR, Guthrie JL, Laukens K, Miotto P, Ofori-Anyinam B, Dreyer V, Supply P, Suresh A, Utpatel C, van Soolingen D, Zhou Y, Ashton PM, Brites D, Cabibbe AM, de Jong BC, de Vos M, Menardo F, Gagneux S, Gao Q, Heupink TH, Liu Q, Loiseau C, Rigouts L, Rodwell TC, Tagliani E, Walker TM, Warren RM, Zhao Y, Zignol M, Schito M, Gardy J, Cirillo DM, Niemann S, Comas I, Van Rie A.

Nat Rev Microbiol. 2019 Sep;17(9):533-545. doi: 10.1038/s41579-019-0214-5. Review.

PMID:
31209399
2.

Isoniazid Resistance in Mycobacterium tuberculosis Is a Heterogeneous Phenotype Composed of Overlapping MIC Distributions with Different Underlying Resistance Mechanisms.

Ghodousi A, Tagliani E, Karunaratne E, Niemann S, Perera J, Köser CU, Cirillo DM.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00092-19. doi: 10.1128/AAC.00092-19. Print 2019 Jul.

3.

Role and value of whole genome sequencing in studying tuberculosis transmission.

Nikolayevskyy V, Niemann S, Anthony R, van Soolingen D, Tagliani E, Ködmön C, van der Werf MJ, Cirillo DM.

Clin Microbiol Infect. 2019 Apr 11. pii: S1198-743X(19)30124-7. doi: 10.1016/j.cmi.2019.03.022. [Epub ahead of print] Review.

PMID:
30980928
4.

EUSeqMyTB to set standards and build capacity for whole genome sequencing for tuberculosis in the EU.

Tagliani E, Cirillo DM, Ködmön C, van der Werf MJ; EUSeqMyTB Consortium.

Lancet Infect Dis. 2018 Apr;18(4):377. doi: 10.1016/S1473-3099(18)30132-4. Epub 2018 Mar 21. No abstract available.

PMID:
29582760
5.

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.

Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C, Hanna D, Kim PS, Liwski R, Zignol M, Gilpin C, Niemann S, Denkinger CM, Fleming J, Warren RM, Crook D, Posey J, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Murray M, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, Ranganathan UDK, McNerney R, Ezewudo M, Cirillo DM, Schito M, Köser CU, Rodwell TC.

Eur Respir J. 2017 Dec 28;50(6). pii: 1701354. doi: 10.1183/13993003.01354-2017. Print 2017 Dec.

6.

Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey.

Tagliani E, Hassan MO, Waberi Y, De Filippo MR, Falzon D, Dean A, Zignol M, Supply P, Abdoulkader MA, Hassangue H, Cirillo DM.

Sci Rep. 2017 Dec 15;7(1):17672. doi: 10.1038/s41598-017-17705-3.

7.

H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition.

Nancy P, Siewiera J, Rizzuto G, Tagliani E, Osokine I, Manandhar P, Dolgalev I, Clementi C, Tsirigos A, Erlebacher A.

J Clin Invest. 2018 Jan 2;128(1):233-247. doi: 10.1172/JCI95937. Epub 2017 Nov 27.

8.

Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.

Ngabonziza JCS, Diallo AB, Tagliani E, Diarra B, Kadanga AE, Togo ACG, Thiam A, de Rijk WB, Alagna R, Houeto S, Ba F, Dagnra AY, Ivan E, Affolabi D, Schwoebel V, Trebucq A, de Jong BC, Rigouts L, Daneau G; “Union short MDR-TB regimen study group”.

PLoS One. 2017 Oct 31;12(10):e0187211. doi: 10.1371/journal.pone.0187211. eCollection 2017.

9.

Evaluation of Mycobacterium tuberculosis viability in OMNIgene-SPUTUM reagent upon multi-day transport at ambient temperature.

Tagliani E, Alagna R, Tafaj S, Hafizi H, Cirillo DM.

BMC Infect Dis. 2017 Oct 2;17(1):663. doi: 10.1186/s12879-017-2756-3.

10.

The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.

Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, Banada PP, Deshpande S, Shenai S, Gall A, Glass J, Krieswirth B, Schumacher SG, Nabeta P, Tukvadze N, Rodrigues C, Skrahina A, Tagliani E, Cirillo DM, Davidow A, Denkinger CM, Persing D, Kwiatkowski R, Jones M, Alland D.

MBio. 2017 Aug 29;8(4). pii: e00812-17. doi: 10.1128/mBio.00812-17.

11.

Limited Colonization Undermined by Inadequate Early Immune Responses Defines the Dynamics of Decidual Listeriosis.

Rizzuto G, Tagliani E, Manandhar P, Erlebacher A, Bakardjiev AI.

Infect Immun. 2017 Jul 19;85(8). pii: e00153-17. doi: 10.1128/IAI.00153-17. Print 2017 Aug.

12.

Reaching consensus on drug resistance conferring mutations.

Cirillo DM, Miotto P, Tagliani E; ReSeqTB Consortium.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S33. doi: 10.1016/j.ijmyco.2016.11.009. Epub 2016 Nov 25. No abstract available.

13.

Reaching consensus on drug resistance conferring mutations.

Cirillo DM, Miotto P, Tagliani E; ReSeqTB Consortium.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S31-S32. doi: 10.1016/j.ijmyco.2016.09.062. Epub 2016 Nov 15.

14.

Mycobacterium sherrisii Pulmonary Disease, Burkina Faso.

Borroni E, Badoum G, Cirillo DM, Matteelli A, Moyenga I, Ouedraogo M, Roggi A, Saleri N, Tagliani E, Tortoli E.

Emerg Infect Dis. 2015 Nov;21(11):2093-4. doi: 10.3201/eid2111.141809. No abstract available.

15.

Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.

Tagliani E, Cabibbe AM, Miotto P, Borroni E, Toro JC, Mansjö M, Hoffner S, Hillemann D, Zalutskaya A, Skrahina A, Cirillo DM.

J Clin Microbiol. 2015 Sep;53(9):2961-9. doi: 10.1128/JCM.01257-15. Epub 2015 Jul 15.

16.

The impact of Xpert® MTB/RIF depends on service coordination: experience in Burkina Faso.

Moyenga I, Roggi A, Sulis G, Diande S, Tamboura D, Tagliani E, Castelli F, Matteelli A.

Int J Tuberc Lung Dis. 2015 Mar;19(3):285-7. doi: 10.5588/ijtld.14.0629.

PMID:
25686135
17.

Cis-acting pathways selectively enforce the non-immunogenicity of shed placental antigen for maternal CD8 T cells.

Tay CS, Tagliani E, Collins MK, Erlebacher A.

PLoS One. 2013 Dec 31;8(12):e84064. doi: 10.1371/journal.pone.0084064. eCollection 2013.

18.

Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface.

Nancy P, Tagliani E, Tay CS, Asp P, Levy DE, Erlebacher A.

Science. 2012 Jun 8;336(6086):1317-21. doi: 10.1126/science.1220030.

19.

Dendritic cell function at the maternal-fetal interface.

Tagliani E, Erlebacher A.

Expert Rev Clin Immunol. 2011 Sep;7(5):593-602. doi: 10.1586/eci.11.52.

20.

Coordinate regulation of tissue macrophage and dendritic cell population dynamics by CSF-1.

Tagliani E, Shi C, Nancy P, Tay CS, Pamer EG, Erlebacher A.

J Exp Med. 2011 Aug 29;208(9):1901-16. doi: 10.1084/jem.20110866. Epub 2011 Aug 8.

21.

Expression of Wiskott-Aldrich syndrome protein in dendritic cells regulates synapse formation and activation of naive CD8+ T cells.

Pulecio J, Tagliani E, Scholer A, Prete F, Fetler L, Burrone OR, Benvenuti F.

J Immunol. 2008 Jul 15;181(2):1135-42.

22.

Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.

Tagliani E, Guermonprez P, Sepúlveda J, López-Bravo M, Ardavín C, Amigorena S, Benvenuti F, Burrone OR.

J Immunol. 2008 Mar 1;180(5):3201-9.

Supplemental Content

Loading ...
Support Center